
Walmart will cover over 250 prescriptions at no cost to employees starting in 2027, including Ozempic and Mounjaro for Type 2 diabetes, while expanding benefits like cancer specialist access and neonatal ICU leave to attract and retain workers amid rising healthcare costs.
AI-generated summary
Walmart has faced criticism in the past for its healthcare benefits and wages, prompting a multi-year effort to improve employee compensation and benefits to enhance retention and public perception.
Walmart plans to cover more than 250 prescriptions, including some insulin, inhalers and GLP-1s for diabetes, at no cost to its employees in 2027, the company confirmed to CNBC on Tuesday.
The retailer is also expanding existing benefits and adding new ones to attract and retain workers at a time when many other employers are offsetting rising healthcare costs with higher prices and scaled-back plan benefits. The announcement comes weeks before open enrollment for Walmart employees closes on Nov. 6.
Walmart, the biggest private employer in the U.S., will offer Novo's diabetes injection Ozempic and Eli Lilly's rival shot Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.
But the company still does not cover GLP-1s from Novo and Lilly for the purpose of weight loss. Other large employers similarly don't cover those treatments for obesity or have recently dropped coverage to tamp down on their healthcare costs.
The latest benefit changes build on Walmart's years-long effort to boost employee compensation after previously receiving criticism for the healthcare benefits and wages it offers. Walmart employs roughly 2.1 million associates worldwide, with about 1.6 million of those workers based in the U.S., as of the end of fiscal year 2026.
In a statement, the company said it's minimizing premium increases for its employees, raising rates for its starting plan by $1.50 per pay period to $39.80. Walmart told CNBC that's a smaller increase than the company made last year.
The company is also expanding an existing benefit that pays for employees to see cancer specialists at the Mayo Clinic or the Cleveland Clinic, according to a Tuesday letter to workers from Donna Morris, Walmart's chief people officer. Starting next year, employees under most plans can use that benefit to get a second opinion from a specialist for rare conditions such as ALS, multiple sclerosis and Parkinson's.
Among the other added benefits is 12 weeks of neonatal intensive care unit leave for parents, which can be added on top of regular parental and maternity leave, the letter said.
"The steps we're taking are based on years of planning and trying new things, which is allowing us to make meaningful improvements for associates without slashing benefits or significantly raising premiums," Walmart said in its statement to CNBC.
AI outlook — possibilities, not facts
Walmart will see improved employee retention rates in 2027 and 2028 following the implementation of expanded healthcare benefits.
Likely · Within months
Other large U.S. employers may face increased pressure to expand diabetes medication coverage to remain competitive in hiring.
Possible · Within months

Bumble has agreed to a $1.3 billion acquisition by Ithaca Holdings, transitioning the dating app to a private company. The move follows significant declines in revenue and paying users, with founder Whitney Wolfe Herd planning to remain involved.

The National Payments Corporation of India has delayed a planned 0.4% merchant fee on UPI transactions over ₹2,000 following widespread opposition from retailers. The rollout is postponed until after the Diwali festival to avoid disrupting the peak shopping season.

Getty Images plans to file for Chapter 11 bankruptcy and go private after a failed merger with Shutterstock. The company secured $533 million in funding to reduce its $1.3 billion debt load, with the restructuring expected to conclude by the end of the year.

A chatbot startup is seeking to sell its assets to Disney following years of legal challenges and safety concerns.

Stanford's Robert Hall and Columbia's Michael Woodford won the Nobel Prize in economics for laying the microeconomic foundations of macroeconomic stabilization and New Keynesian economics.

UnitedHealth Group reported third-quarter adjusted earnings of $4.69 per share on $112.69 billion in revenue, beating Wall Street estimates, and raised its full-year profit outlook.